home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

51.59 +0.08 (+0.16%)

Streaming Delayed Price Updated: 3:40 PM EDT, Aug 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

45 46 Next >

Analyzing GSK's Short Interest ↗

June 15, 2022

GSK's (NYSE:GSK) short percent of float has fallen 17.24% since its last report. The company recently reported that it has 6.02 million shares sold short, which is 0.24% of all...

Via Benzinga

Antibiotic Makers Adopt Their Own Environmental Safeguard Standards ↗

June 15, 2022

Via Benzinga

Morning Brief: Top Financial Stories Dominating on Monday, June 13 ↗

June 13, 2022

CNBC JPMorgan Remains Bullish On Alibaba And Other Chinese Stocks - Here’s Why

Via Benzinga

Sanofi-GSK's Next-Gen COVID-19 Booster Shows Potential Against Variants Of Concern ↗

June 13, 2022

Via Benzinga

Morning Brief: Top Financial Stories Dominating on Friday, June 10 ↗

June 10, 2022

Reuters Rebranded McDonald’s Restaurants To Reopen In Russia

Via Benzinga

GSK Shows Positive Pivotal Phase III Data For Its RSV Vaccine Candidate ↗

June 10, 2022

Via Benzinga

FDA Approves GSK's Measles Vaccine ↗

June 06, 2022

Via Benzinga

Breakthroughs In Treating Killer Diseases Could Lengthen Life

June 07, 2022

Palm Beach, FL – June 7, 2022 – FinancialNewsMedia.com News Commentary – According to the World Health Organization, top global killers include heart failure, COPD, cancers, Alzheimer’s, neonatal...

Via FinancialNewsMedia

Topics Death

GSK announces US FDA approval of PRIORIX for the prevention of measles, mumps and rubella in individuals 12 months of age and older

June 06, 2022

From GSK plc

Via Business Wire

Morning Brief: Top Financial Stories Dominating on Monday, June 6 ↗

June 06, 2022

Reuters

Via Benzinga

GlaxoSmithKline: Dividend Insights ↗

May 16, 2022

Wednesday marks the last chance for investors to receive the next dividend payout from GlaxoSmithKline (NYSE:GSK).

Via Benzinga

The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More ↗

June 05, 2022

Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended.

Via Benzinga

Week In Review: Vivo Raises $600 Million In First Tranche Of China PE Fund ↗

June 04, 2022

Vivo Capital held its first closing of a yuan-denominated private equity fund at $600 million, with a target of bringing the fund to $1.5 billion. Meanwhile, ProfoundBio closed a $70 million Series A+...

Via Talk Markets

6 Biotech Stocks to Buy Now Ahead of These June Catalysts ↗

June 03, 2022

These biotech stocks face some key make-or-break events in June that could have big implication for their futures.

Via InvestorPlace

3 Undervalued Dividend Growth Stocks ↗

June 01, 2022

Investors who focus on a strategy of dividend growth stocks have performed better than some broader stock market indices.

Via InvestorPlace

GSK Confirms Consumer Healthcare Unit Spin-off: What Investors Should Know ↗

June 01, 2022

Close on the heels of an M&A deal, GlaxoSmithKline plc (NYSE: GSK) confirmed the spin-off of the consumer healthcare business it jointly owns with U.S. pharma giant Pfizer, Inc.

Via Benzinga

Morning Brief: Top Financial Stories Dominating on Wednesday, June 1 ↗

June 01, 2022

Reuters Redbird Capital Buys Italian Football Club AC Milan

Via Benzinga

Pfizer To Quit GSK's Consumer Health JV Following Its Spin-Off ↗

June 01, 2022

Via Benzinga

3 Biotech Stocks to Buy Before They Boom ↗

June 01, 2022

It could be a “never-before, never-after opportunity” to buy into these biotech stocks that trade at very attractive valuations.

Via InvestorPlace

Unilever Jumps After Nelson Peltz Joins Board ↗

May 31, 2022

Unilever plc (NYSE: UL) shares traded higher by 8% on Tuesday after the company announced activist investor Nelson Peltz is joining the company's board of directors.

Via Benzinga

GlaxoSmithKline Announces $3.3 Billion Buyout To Square Off With Pfizer, Merck ↗

May 31, 2022

The deal could vastly expand GlaxoSmithKline's vaccine offerings.

Via Investor's Business Daily

Morning Brief: Top Financial Stories Dominating on Tuesday, May 31 ↗

May 31, 2022

CNBC Opportunities In Crypto Crash? Top Crypto Firms Hunt For Takeovers

Via Benzinga

GSK To Scoop Clinical Stage US Biotech Affinivax For $3.3B To Shore Up Vaccine Business ↗

May 31, 2022

Via Benzinga

Unilever To Add This Activist Investor To Board - What's The Catch? ↗

May 31, 2022

Via Benzinga

Dow Up Nearly 300 Points, Eyeing Seventh-Straight Daily Win ↗

May 27, 2022

An upbeat core personal consumption expenditures price index for April is boosting investor sentiment at midday after it showed slowing inflation.

Via Talk Markets

Nicotine Surges as Smoking Sags

May 24, 2022

Via Investor Brand Network

Nicotine Surges as Smoking Sags

May 24, 2022

NetworkNewsWire Editorial Coverage New York, NY – May 24, 2022 – Seems like yesterday people were smoking cigarettes everywhere; many people still have memories of Grandpa puffing on his Camels. It...

Via FinancialNewsMedia

GSK Turnaround Story ↗

May 18, 2022

GSK is already gearing up for what it hopes will be a bright future. On April 13, GlaxoSmithKline announced a $1.9 billion deal to purchase a U.S. biotech company, Sierra Oncology.

Via Talk Markets

Large Cap Biopharmaceuticals: Provide Growth, Value And Yield ↗

May 16, 2022

Now that all major biopharmaceutical earnings are in, we can review the financial metrics and see if our portfolio needs re-balancing.

Via Talk Markets

HC Wainwright Says This Stock Is Well Capitalized For Value Realization Of Pipeline, Despite COVID-19 Uncertainty ↗

May 12, 2022

Via Benzinga

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

45 46 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com